Scharf Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.71M Sell
93,867
-2,302
-2% -$205K 0.32% 36
2026
Q1
$6.91M Sell
96,169
-7,328
-7% -$565K 0.21% 35
2025
Q4
$8.21M Buy
103,497
+2,107
+2% +$166K 0.22% 37
2025
Q3
$7.64M Sell
101,390
-24,495
-19% -$1.68M 0.19% 37
2025
Q2
$8.68M Sell
125,885
-33,927
-21% -$2.22M 0.25% 31
2025
Q1
$10.8M Sell
159,812
-863,249
-84% -$51.7M 0.33% 28
2024
Q4
$59.6M Sell
1,023,061
-882,094
-46% -$49.5M 1.77% 24
2024
Q3
$120M Sell
1,905,155
-78,453
-4% -$4.58M 3.3% 16
2024
Q2
$117M Sell
1,983,608
-130,993
-6% -$8.19M 3.34% 15
2024
Q1
$169M Sell
2,114,601
-74,951
-3% -$5.73M 4.57% 11
2023
Q4
$173M Sell
2,189,552
-21,954
-1% -$1.56M 4.74% 9
2023
Q3
$154M Buy
2,211,506
+274,276
+14% +$19.4M 4.62% 10
2023
Q2
$134M Buy
1,937,230
+61,171
+3% +$4.35M 4.02% 13
2023
Q1
$139M Buy
1,876,059
+62,697
+3% +$5.26M 4.4% 10
2022
Q4
$169M Buy
1,813,362
+4,070
+0.2% +$393K 5.52% 3
2022
Q3
$173M Sell
1,809,292
-90,820
-5% -$8.99M 6.51% 3
2022
Q2
$176M Sell
1,900,112
-32,740
-2% -$3.2M 6.01% 4
2022
Q1
$196M Buy
1,932,852
+59,267
+3% +$6.23M 5.8% 4
2021
Q4
$193M Sell
1,873,585
-113,745
-6% -$10.5M 5.73% 4
2021
Q3
$169M Sell
1,987,330
-14,794
-0.7% -$1.24M 5.32% 6
2021
Q2
$167M Buy
2,002,124
+75,970
+4% +$6.22M 5.07% 5
2021
Q1
$145M Sell
1,926,154
-6,644
-0.3% -$484K 5.02% 8
2020
Q4
$132M Buy
1,932,798
+271,842
+16% +$17.7M 4.97% 6
2020
Q3
$97M Sell
1,660,956
-48,608
-3% -$3.02M 4.18% 14
2020
Q2
$111M Sell
1,709,564
-32,682
-2% -$2.06M 4.97% 9
2020
Q1
$103M Sell
1,742,246
-20,369
-1% -$1.36M 5.17% 8
2019
Q4
$131M Buy
1,762,615
+62,597
+4% +$4.4M 5.12% 8
2019
Q3
$107M Sell
1,700,018
-76,160
-4% -$4.51M 4.38% 13
2019
Q2
$96.8M Buy
1,776,178
+37,054
+2% +$2M 3.81% 13
2019
Q1
$93.8M Buy
1,739,124
+295,697
+20% +$18.3M 3.62% 14
2018
Q4
$94.6M Buy
1,443,427
+118,826
+9% +$8.87M 3.75% 14
2018
Q3
$104M Sell
1,324,601
-59,953
-4% -$4.29M 3.63% 15
2018
Q2
$89.1M Sell
1,384,554
-247,270
-15% -$16.3M 3.18% 18
2018
Q1
$102M Sell
1,631,824
-127,758
-7% -$9.17M 2.85% 20
2017
Q4
$128M Sell
1,759,582
-703,148
-29% -$51.1M 2.89% 17
2017
Q3
$200M Sell
2,462,730
-33,909
-1% -$2.68M 4.86% 6
2017
Q2
$201M Buy
2,496,639
+91,464
+4% +$7.22M 4.72% 6
2017
Q1
$189M Sell
2,405,175
-104,692
-4% -$8.36M 4.52% 10
2016
Q4
$198M Buy
2,509,867
+267,324
+12% +$21.6M 4.59% 10
2016
Q3
$200M Buy
2,242,543
+8,152
+0.4% +$769K 4.63% 10
2016
Q2
$214M Buy
2,234,391
+319,545
+17% +$31.8M 4.81% 8
2016
Q1
$199M Buy
1,914,846
+76,797
+4% +$7.47M 4.62% 8
2015
Q4
$180M Buy
1,838,049
+72,134
+4% +$7.06M 4.29% 10
2015
Q3
$170M Sell
1,765,915
-45,762
-3% -$4.81M 4.47% 9
2015
Q2
$190M Buy
1,811,677
+92,883
+5% +$9.49M 4.87% 5
2015
Q1
$177M Buy
1,718,794
+132,030
+8% +$13.4M 4.92% 4
2014
Q4
$153M Sell
1,586,764
-123,146
-7% -$10.9M 4.59% 9
2014
Q3
$136M Buy
1,709,910
+145,130
+9% +$11.4M 4.81% 5
2014
Q2
$118M Buy
1,564,780
+71,949
+5% +$5.44M 4.58% 7
2014
Q1
$112M Buy
1,492,831
+10,696
+0.7% +$756K 4.97% 4
2013
Q4
$106M Sell
1,482,135
-71,544
-5% -$4.6M 4.75% 2
2013
Q3
$88.2M Buy
1,553,679
+61,055
+4% +$3.64M 4.17% 16
2013
Q2
$85.3M Buy
+1,492,624
New +$86.5M 4.63% 7

Other funds holding CVS

Scharf Investments's CVS Position: Q2 2026 in Review

Scharf Investments reduced its CVS Health (CVS) stake by 2.4% in Q2 2026, selling an estimated $205K and leaving 93,867 shares worth $9.71M. The position accounts for 0.32% of the portfolio, ranked #36.

Scharf Investments first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $214M in Q2 2016. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Scharf Investments held 93,867 shares of CVS Health worth $9.71M as of Q2 2026.
  • Scharf Investments sold 2,302 CVS Health shares in Q2 2026, an estimated $205K.
  • CVS Health made up 0.32% of Scharf Investments's portfolio in Q2 2026, its #36 holding.
  • Scharf Investments first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Scharf Investments's CVS Health position peaked at $214M in Q2 2016.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Scharf Investments's 13F filing for Q2 2026, filed 13 Jul 2026.